HKThe article discusses the growing significance of the 'silver economy' and longevity medicine in Asia, particularly focusing on China's aging population and its economic implications. It highlights that China's population over 60 years old has reached 320 million, expected to rise to 400 million by 2035. Longevity medicine, which aims to extend healthy lifespan through scientific interventions, is gaining traction globally, with the market projected to grow significantly. The piece emphasizes Hong Kong's potential to become a leading center for longevity research, clinical trials, regulation, and investment.
Bias read (Center): While the article addresses a politically sensitive topic related to demographics and economic strategy, it presents information objectively without overtly favoring any particular political ideology. The focus is on economic trends and scientific advancements rather than partisan advocacy. The tone
